JNJ vs MCD: Which Is the Better Buy?
Side-by-side comparison of Johnson & Johnson and McDonald's Corporation — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-25.
Johnson & Johnson · Healthcare
$270.68
+5.7% upside to fair value
Med Conviction
Grade C
High Quality
VS
McDonald's Corporation · Consumer Cyclical
$252.78
+40.7% upside to fair value
Med Conviction
Grade A
High Quality
QuantHub Verdict
MCD has more upside to fair value
(+40.7%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
JNJ |
MCD |
| Current Price |
$270.68 |
$252.78 |
| Fair Value Estimate |
$286.05 |
$355.71 |
| Upside to Fair Value |
+5.7%
|
+40.7%
|
| Market Cap |
$652.3B |
$179.6B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
20.2x
|
15.5x
|
| Price / Sales |
6.7x
|
6.5x
|
| Price / FCF |
35.3x
|
23.1x
|
| Revenue Growth YoY |
+6.6%
|
+3.8%
|
| Gross Margin |
67.9%
|
57.4%
|
| Operating Margin |
26.8%
|
45.8%
|
| Return on Equity |
25.7%
|
-561.2%
|
| Dividend Yield |
1.95% |
2.94% |
| FCF Yield |
2.83%
|
4.32%
|
| Analyst Consensus |
Buy
|
Buy
|
Investment Thesis
Johnson & Johnson is a 141,700-employee healthcare holding company operating two segments, Innovative Medicine (immunology, oncology, neuroscience, infectious disease, cardiovascular and metabolism, pulmonary hypertension) and MedTech (interventional solutions, orthopaedics, surgery, vision), founded in 1887 and headquartered in New Brunswick, New Jersey. Business quality is high on fundamentals:…
McDonald's operates a globally scaled, approximately 95% franchised restaurant system with 46,028 restaurants in more than 100 countries, combining a powerful consumer brand, real-estate-backed franchise economics, supplier scale and digital loyalty reach. Business quality is high despite meaningful leverage: TTM gross, operating and net margins are 57.4%, 45.8% and 31.7%, respectively, while loy…
Accumulation Zones
| Metric |
JNJ |
MCD |
| Zone Low |
$214.54 |
$266.78 |
| Zone High |
$243.14 |
$302.35 |
| In Buy Zone? |
No
|
Yes
|